2006
DOI: 10.1001/archotol.132.8.860-b
|View full text |Cite
|
Sign up to set email alerts
|

S096 Nomogram for Predicting Locoregional Recurrence-Free Survival After Treatment of Oral Cavity Squamous Cell Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The use of artificial neural networks and nomograms has been reported widely in prediction of outcomes in certain diseases such as prostate cancer [30,31], sarcoma [32], gastric carcinoma [33], and breast cancer [34]. A logistic regression-based nomogram has also been developed for quantifying the risk for local recurrence in oral cancer patients [35]. The development and validation of these new computational methods is of obvious interest to clinicians in terms of allowing quantification of risk and predicting outcomes in individual patients [35,36].…”
Section: Future Directionsmentioning
confidence: 99%
See 1 more Smart Citation
“…The use of artificial neural networks and nomograms has been reported widely in prediction of outcomes in certain diseases such as prostate cancer [30,31], sarcoma [32], gastric carcinoma [33], and breast cancer [34]. A logistic regression-based nomogram has also been developed for quantifying the risk for local recurrence in oral cancer patients [35]. The development and validation of these new computational methods is of obvious interest to clinicians in terms of allowing quantification of risk and predicting outcomes in individual patients [35,36].…”
Section: Future Directionsmentioning
confidence: 99%
“…A logistic regression-based nomogram has also been developed for quantifying the risk for local recurrence in oral cancer patients [35]. The development and validation of these new computational methods is of obvious interest to clinicians in terms of allowing quantification of risk and predicting outcomes in individual patients [35,36]. However, meaningful comparisons of efficacy of treatment and outcome between groups of patients will still require ''stage grouping'' and this is likely to be based on a range of prognostic scores rather than the traditional partitions in the TNM system.…”
Section: Future Directionsmentioning
confidence: 99%